Puttagunta Chetan
SEC-identified person · CIK 1695859 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Elastic N.V. ESTC | Director | filed 2018 - 2025 |
| Confluent, Inc. CFLT | Officer | filed 2021 - 2022 |
| Amplitude, Inc. AMPL] | Director | filed 2021 - 2022 |
| Nextdoor Holdings, Inc. NXDR | Officer | filed 2021 - 2021 |
| Achaogen, Inc. AKAO | Officer | filed 2018 - 2018 |
| Aveo Pharmaceuticals, INC. AVEO | Officer | filed 2018 - 2018 |
| Genocea Biosciences, INC. GNCA | Officer | filed 2018 - 2018 |
| X4 Pharmaceuticals, Inc XFOR | Officer | filed 2017 - 2017 |
| Regulus Therapeutics Inc. RGLS | Officer | filed 2017 - 2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.